Conference Chairman
Dominique PV de Kleijn Professor Experimental Vascular Surgery; Professor Netherlands Heart Institute, University Medical Center Utrecht |
Keynote Speakers
Catherine Alix-Panabières Director of the Laboratory of Rare Human Circulating Tumor Cells, University Medical Centre of Montpellier |
Giovanni Camussi Professor, University of Torino |
Daniel Chiu A. Bruce Montgomery Professor of Chemistry, University of Washington |
Niek Dekker Principal Scientist, Discovery Sciences, AstraZeneca |
Jennifer Jones NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute |
Fred Kramer Professor of Microbiology, Biochemistry & Molecular Genetics, New Jersey Medical School Rutgers University |
Lucia Languino Professor of Cancer Biology, Thomas Jefferson University |
Sai Kiang Lim Research Director, Institute of Medical Biology, A*STAR |
Minetta Liu Associate Professor and Chair, Oncology Research, Mayo Clinic |
Takahiro Ochiya Professor, Department of Molecular and Cellular Medicine, Tokyo Medical University |
Klaus Pantel Chairman, Department of Tumor Biology, University Medical Center Hamburg-Eppendorf |
Patrizia Paterlini-Brechot Professor of Oncology/Molecular Biology, University Paris Descartes |
Dominique PV de Kleijn Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands |
Paul Robbins Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School |
Leon Terstappen Chair Medical CellBiophysics, MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente |
Alain Thierry Director of Research, Institut de Recherche en Cancérologie de Montpellier-INSERM |
Hans van Leeuwen Professor and Dean, Erasmus University Medical Center |
OverviewSELECTBIO Exosomes and Liquid Biopsies Europe 2018 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby circulating biomarkers of various classes are being evaluated for their potential to be developed into minimally-invasive diagnostics and liquid biopsies for cancer as well as other disease classes. This Exosomes and Liquid Biopsies 2018 Conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), protein-based circulating biomarkers, and exosomes/extracellular vesicles (EVs). There is much interest in the potential of ctDNA and EVs for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this conference bring together the most up-to-date information and current state-of-the-field. The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early patient monitoring. Another component of this conference is the exploration of the science behind Exosomes and Extracellular Vesicles -- Diagnostic and Therapeutic Potential. The conference is being held in Rotterdam, The Netherlands-an excellent venue for networking with connections across The Netherlands, Europe and Worldwide. The conference includes an exhibition bringing together companies from around the world focused on developing technologies, tools, products and services serving the liquid biopsy field. The Conference Chairman and Chief Scientific Advisor is Professor Dominique de Kleijn, Professor, University Medical Center Utrecht, The Netherlands.
Agenda Topics- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
- Emerging Technologies and Emerging Companies Showcase
- Exosomes and Extracellular Vesicles (EVs): Potential for Development of Liquid Biopsies
- Exosomes as Delivery Vehicles and Therapeutic Applications of Exosomes
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
- Extracellular Vesicles (EV) in Cancer, Cardiovascular Disease, Neurological Diseases and Beyond
- Grants and Awards across the EU for Exosomes and Liquid Biopsy Research
- Regulatory Landscape for Liquid Biopsies (EU, US and Asia/Pacific)
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Distinguished FacultyEsther Nolte-‘t Hoen, Assistant Professor, Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University Niek Maas, Clinical Researcher, University Medical Center Utrecht Valérie Taly, CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité Irina Nazarenko, Exosome and Tumor Biology Group Leader, University of Freiburg Francoise Farace, Head of Rare Circulating Cells Translational Laboratory, INSERM Gustave Roussy Institute Randolph Corteling, Head of Research, ReNeuron Ltd. Jens Habermann, Head, Section of Translational Surgical Oncology and Biobanking & Scientific Director, Surgical Center for Translational Oncology, Department of Surgery & Institute of Human Genetics, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck Peter Rhein, Instrument Application Scientist, Merck KGaA Felix Jansen, Leader of the Microvesicle Research Group, Department for Cardiology, Pulmology and Angiology, University Hospital Bonn Yael Heifetz, Principal Investigator, The Hebrew University of Jerusalem An Hendrix, Professor, Ghent University Jo Vandesompele, Professor, Ghent University and CSO, Biogazelle Pierre Laurent, Professor, Universite Paris Descartes Yves Rozenholc, Professor, University of Paris Descartes Tomoko Yoshino, Professor, Tokyo University of Agriculture and Technology Alain Brisson, Professor Emeritus, University of Bordeaux Gerrit Meijer, Professor of Oncologic Pathology, Netherlands Cancer Institute Nikolas Stoecklein, Professor, Experimental Surgical Oncology, Heinrich Heine University Düsseldorf Marcin Jurga, R&D Director, The Cell Factory bvba Maria Giraldez, Researcher, University of Michigan Florent Mouliere, Researcher, Nitzan Rosenfeld Group, University of Cambridge Alison Devonshire, Science Leader, LGC Limited Christa Noehammer, Senior Scientist, Austrian Institute of Technology Clotilde Costa, Translational Medical Oncology Group, Joint Unit Roche-Chus, Oncomet, Universitary Cinical Hospital of Santiago de Compostela
|
Corporate Sponsors | Web Sponsors | Offical Journal Partner | Networking |
| | | |
|